Alignment Healthcare, Inc.ALHCEarnings & Financial Report
Alignment Healthcare, Inc. is a U.S.-based healthcare provider offering Medicare Advantage plans for seniors. It adopts a value-based care model, partnering with local providers to deliver personalized coordinated medical services, prescription drug coverage and supplemental benefits to members across multiple U.S. states.
ALHC Q1 FY2026 Key Financial Metrics
Revenue
$1.2B
Gross Profit
N/A
Operating Profit
N/A
Net Profit
$11.4M
Gross Margin
N/A
Operating Margin
N/A
Net Margin
0.9%
YoY Growth
-74.7%
Alignment Healthcare, Inc. Q1 FY2026 Financial Summary
Alignment Healthcare, Inc. reported revenue of $1.2B (down 74.7% YoY) for Q1 FY2026, with a net profit of $11.4M (0.9% margin).
Key Financial Metrics
| Total Revenue | $1.2B |
|---|---|
| Net Profit | $11.4M |
| Gross Margin | N/A |
| Operating Margin | N/A |
| Report Period | Q1 FY2026 |
Alignment Healthcare, Inc. Annual Revenue by Year
Alignment Healthcare, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $3.9B).
Alignment Healthcare, Inc. Quarterly Revenue & Net Profit History
Alignment Healthcare, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q1 FY2026 | $1.2B | -74.7% | $11.4M | 0.9% |
| Q4 FY2025 | $1.0B | +44.4% | $-11.0M | -1.1% |
| Q3 FY2025 | $993.7M | +43.5% | $3.7M | 0.4% |
| Q2 FY2025 | $1.0B | +49.0% | $15.7M | 1.5% |
| Q1 FY2025 | $926.9M | +47.5% | $-9.1M | -1.0% |
| Q4 FY2024 | $701.2M | +52.8% | $-31.1M | -4.4% |
| Q3 FY2024 | $692.4M | +53.8% | $-26.4M | -3.8% |
| Q2 FY2024 | $681.3M | +49.1% | $-24.0M | -3.5% |
Income Statement
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $681.3M | $692.4M | $701.2M | $926.9M | $1.02B | $993.7M | $1.01B | $1.24B |
| YoY Growth | 49.1% | 53.8% | 52.8% | 47.5% | 49.0% | 43.5% | 44.4% | -74.7% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $716.3M | $692.3M | $782.1M | $895.6M | $1.00B | $1.10B | $1.07B | $1.26B |
| Liabilities | $591.5M | $576.7M | $681.1M | $786.6M | $859.2M | $940.7M | $886.5M | $1.05B |
| Equity | $123.7M | $114.5M | $99.9M | $108.1M | $141.0M | $161.9M | $179.3M | $206.9M |
Cash Flow
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $23.5M | $26.2M | $-8.7M | $16.6M | $29.1M | $144.6M | $-50.4M | $128.7M |